316 related articles for article (PubMed ID: 23408627)
21. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
Buge SL; Richardson E; Alipanah S; Markham P; Cheng S; Kalyan N; Miller CJ; Lubeck M; Udem S; Eldridge J; Robert-Guroff M
J Virol; 1997 Nov; 71(11):8531-41. PubMed ID: 9343211
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques.
Malkevitch N; Rohne D; Pinczewski J; Aldrich K; Kalyanaraman VS; Letvin NL; Robert-Guroff M
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):235-44. PubMed ID: 15018712
[TBL] [Abstract][Full Text] [Related]
23. Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
Martins MA; Gonzalez-Nieto L; Ricciardi MJ; Bailey VK; Dang CM; Bischof GF; Pedreño-Lopez N; Pauthner MG; Burton DR; Parks CL; Earl P; Moss B; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI
J Virol; 2020 Nov; 94(24):. PubMed ID: 33028714
[TBL] [Abstract][Full Text] [Related]
24. Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4
Sauermann U; Radaelli A; Stolte-Leeb N; Raue K; Bissa M; Zanotto C; Krawczak M; Tenbusch M; Überla K; Keele BF; De Giuli Morghen C; Sopper S; Stahl-Hennig C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904195
[TBL] [Abstract][Full Text] [Related]
25. DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.
Manrique M; Micewicz E; Kozlowski PA; Wang SW; Aurora D; Wilson RL; Ghebremichael M; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):505-19. PubMed ID: 18373436
[TBL] [Abstract][Full Text] [Related]
26. Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.
Patterson LJ; Kuate S; Daltabuit-Test M; Li Q; Xiao P; McKinnon K; DiPasquale J; Cristillo A; Venzon D; Haase A; Robert-Guroff M
Clin Vaccine Immunol; 2012 May; 19(5):629-37. PubMed ID: 22441384
[TBL] [Abstract][Full Text] [Related]
27. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses.
Ko EJ; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Hoang T; Robert-Guroff M
Front Immunol; 2019; 10():779. PubMed ID: 31031768
[TBL] [Abstract][Full Text] [Related]
28. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
[TBL] [Abstract][Full Text] [Related]
29. Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.
Xiao P; Patterson LJ; Kuate S; Brocca-Cofano E; Thomas MA; Venzon D; Zhao J; DiPasquale J; Fenizia C; Lee EM; Kalisz I; Kalyanaraman VS; Pal R; Montefiori D; Keele BF; Robert-Guroff M
J Virol; 2012 Apr; 86(8):4644-57. PubMed ID: 22345466
[TBL] [Abstract][Full Text] [Related]
30. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
31. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
[TBL] [Abstract][Full Text] [Related]
32. Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity.
Chaudhary O; Wang L; Bose D; Narayan V; Yeh MT; Carville A; Clements JD; Andino R; Kozlowski PA; Aldovini A
AIDS Res Hum Retroviruses; 2020 Dec; 36(12):984-997. PubMed ID: 32962398
[TBL] [Abstract][Full Text] [Related]
33. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
Stolte-Leeb N; Bieler K; Kostler J; Heeney J; Haaft PT; Suh YS; Hunsmann G; Stahl-Hennig C; Wagner R
Viral Immunol; 2008 Jun; 21(2):235-46. PubMed ID: 18476770
[TBL] [Abstract][Full Text] [Related]
34. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
35. Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.
Curtis AD; Walter KA; Nabi R; Jensen K; Dwivedi A; Pollara J; Ferrari G; Van Rompay KKA; Amara RR; Kozlowski PA; De Paris K
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):310-325. PubMed ID: 30303405
[TBL] [Abstract][Full Text] [Related]
36. T
Helmold Hait S; Hogge CJ; Rahman MA; Hunegnaw R; Mushtaq Z; Hoang T; Robert-Guroff M
Front Immunol; 2020; 11():608003. PubMed ID: 33584682
[TBL] [Abstract][Full Text] [Related]
37. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
[TBL] [Abstract][Full Text] [Related]
38. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
Kannanganat S; Nigam P; Velu V; Earl PL; Lai L; Chennareddi L; Lawson B; Wilson RL; Montefiori DC; Kozlowski PA; Moss B; Robinson HL; Amara RR
J Immunol; 2010 Dec; 185(12):7262-73. PubMed ID: 21076059
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
[TBL] [Abstract][Full Text] [Related]
40. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
